Trials / NCT01914913
Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa
Status unknown Phase 1 / Phase 2 Cell therapy
- Sponsor
- Chaitanya Hospital, Pune
- Treatment
- BMMNCs
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to 65 Years
- Enrollment
- 15 participants
- Started
- 2014-09
- Main results expected
- 2016-11
- Results posted
- Not yet
- Record last updated
- 2014-09-17
What the study is testing
Retinitis pigmentosa is an eye disease in which there is damage to the retina. The retina is the layer of tissue at the back of the inner eye that converts light images to nerve signals and sends them to the brain.Autologous Bone Marrow derived Mono Nuclear Stem Cell (BMMNCs) is used for this condition .
Where it runs
India (1)
- Chaitanya Hospital, Pune, Maharashtra (recruiting now)